FORMULATIONS CONTAINING REVERSIBLE COVALENT COMPOUNDS
Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production, and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases. L'invention porte sur des fo...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GOLDSTEIN, DAVID MICHAEL BERNER, BRET |
| description | Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production, and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
L'invention porte sur des formulations pharmaceutiques orales qui comportent des composés covalents réversibles ayant une fraction accepteur de Michael, sur leur procédé de fabrication et sur l'utilisation de ces formulations pour le traitement de maladies pouvant être traitées par de tels composés, telles que le cancer et des maladies auto-immunes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2874461C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2874461C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2874461C3</originalsourceid><addsrcrecordid>eNrjZDB18w_yDfVxDPH09wtWcPb3C3H09PP0c1cIcg1zDQr2dPJxBYqGOfq4-oUAGb4B_qF-LsE8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSTe2dHIwtzExMzQ2ZiwCgCTAydW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATIONS CONTAINING REVERSIBLE COVALENT COMPOUNDS</title><source>esp@cenet</source><creator>GOLDSTEIN, DAVID MICHAEL ; BERNER, BRET</creator><creatorcontrib>GOLDSTEIN, DAVID MICHAEL ; BERNER, BRET</creatorcontrib><description>Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production, and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
L'invention porte sur des formulations pharmaceutiques orales qui comportent des composés covalents réversibles ayant une fraction accepteur de Michael, sur leur procédé de fabrication et sur l'utilisation de ces formulations pour le traitement de maladies pouvant être traitées par de tels composés, telles que le cancer et des maladies auto-immunes.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211012&DB=EPODOC&CC=CA&NR=2874461C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211012&DB=EPODOC&CC=CA&NR=2874461C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOLDSTEIN, DAVID MICHAEL</creatorcontrib><creatorcontrib>BERNER, BRET</creatorcontrib><title>FORMULATIONS CONTAINING REVERSIBLE COVALENT COMPOUNDS</title><description>Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production, and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
L'invention porte sur des formulations pharmaceutiques orales qui comportent des composés covalents réversibles ayant une fraction accepteur de Michael, sur leur procédé de fabrication et sur l'utilisation de ces formulations pour le traitement de maladies pouvant être traitées par de tels composés, telles que le cancer et des maladies auto-immunes.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB18w_yDfVxDPH09wtWcPb3C3H09PP0c1cIcg1zDQr2dPJxBYqGOfq4-oUAGb4B_qF-LsE8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSTe2dHIwtzExMzQ2ZiwCgCTAydW</recordid><startdate>20211012</startdate><enddate>20211012</enddate><creator>GOLDSTEIN, DAVID MICHAEL</creator><creator>BERNER, BRET</creator><scope>EVB</scope></search><sort><creationdate>20211012</creationdate><title>FORMULATIONS CONTAINING REVERSIBLE COVALENT COMPOUNDS</title><author>GOLDSTEIN, DAVID MICHAEL ; BERNER, BRET</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2874461C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GOLDSTEIN, DAVID MICHAEL</creatorcontrib><creatorcontrib>BERNER, BRET</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOLDSTEIN, DAVID MICHAEL</au><au>BERNER, BRET</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATIONS CONTAINING REVERSIBLE COVALENT COMPOUNDS</title><date>2021-10-12</date><risdate>2021</risdate><abstract>Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production, and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
L'invention porte sur des formulations pharmaceutiques orales qui comportent des composés covalents réversibles ayant une fraction accepteur de Michael, sur leur procédé de fabrication et sur l'utilisation de ces formulations pour le traitement de maladies pouvant être traitées par de tels composés, telles que le cancer et des maladies auto-immunes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2874461C |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FORMULATIONS CONTAINING REVERSIBLE COVALENT COMPOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A19%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOLDSTEIN,%20DAVID%20MICHAEL&rft.date=2021-10-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2874461C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |